000 01325 a2200373 4500
005 20250515164217.0
264 0 _c20090416
008 200904s 0 0 eng d
022 _a0250-7005
040 _aNLM
_beng
_cNLM
100 1 _aFlis, Sylwia
245 0 0 _aInhibitory effects of 5-fluorouracil and oxaliplatin on human colorectal cancer cell survival are synergistically enhanced by sulindac sulfide.
_h[electronic resource]
260 _bAnticancer research
_cJan 2009
300 _a435-41 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aBALB 3T3 Cells
650 0 4 _aCell Cycle
_xdrug effects
650 0 4 _aCell Growth Processes
_xdrug effects
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aColorectal Neoplasms
_xdrug therapy
650 0 4 _aDrug Synergism
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHT29 Cells
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aOrganoplatinum Compounds
_xadministration & dosage
650 0 4 _aOxaliplatin
650 0 4 _aSulindac
_xadministration & dosage
700 1 _aSpłwiński, Jacek
773 0 _tAnticancer research
_gvol. 29
_gno. 1
_gp. 435-41
999 _c18767634
_d18767634